ENERGIZE: A GLOBAL PHASE 3 STUDY OF MITAPIVAT DEMONSTRATING EFFICACY AND SAFETY IN ADULTS WITH ALPHA- OR BETA-NON–TRANSFUSION-DEPENDENT THALASSEMIA

Authors
Category Primary study
JournalHematology, Transfusion and Cell Therapy
Year 2024
This article has no abstract
Epistemonikos ID: 613d91a6467b06e2d2f33116b60d887dbd62762f
First added on: Feb 19, 2025